Collectively, they suggest that targeting the G6PD-HIF-1α loop aligns with the emerging paradigm of combinatorial strategies against multiple tumor microenvironment components (68) and provide both novel insights and a theoretical foundation for therapeutic strategies aimed at targeting cancer stemness. This evidence concerns the gene HIF1A and cancer.